They condemned the latest move by the pharma industry to justify the use of polyethylene terephthalate (PET) bottle as safe and economical.
"PET bottles may have long term medical consequences for women, especially in the reproductive age group and children. The release of bisphenol A (BPA) and additives like di-ethylhexyl phthalate can blend with the contents and lead to health issues like impaired immune development, increased miscarriage rates, pre- term birth, low birth weight.
In India, PET bottles are used in 70 percent pediatric and liquid geriatric formulations.
Dr A P Dubey, Professor and HoD Pediatrics, Maulana Azad Medical College said that while the potential harmful effects of such toxins and chemicals is manifold, it is time our pharmaceutical and ancillary industry took the right cue from this government ordinance and minimized usage of plastics packaging for various liquid formulations.
"The new resolution by Government is really commendable as it keeps patient safety first," said Dubey.
"The pharma industry uses amber colored glass bottles in certain instances to protect medicine from being exposed to UV light. However their usage is minimal. Also, many patients tend to ignore the shelf-life mentioned on PET containers and the temperature at which drugs need to be stored which could be harmful," said Dr Saini.
